Filing Details
- Accession Number:
- 0001127602-24-007632
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-29 16:35:17
- Reporting Period:
- 2024-02-27
- Accepted Time:
- 2024-02-29 16:35:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 105770 | West Pharmaceutical Services Inc | WST | Surgical & Medical Instruments & Apparatus (3841) | 231210010 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1336007 | Mark Eric Green | 530 Herman O. West Drive Exton PA 19341 | President, Ceo And Board Chair | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-27 | 64,132 | $57.38 | 217,040 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-27 | 64,132 | $359.85 | 152,908 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-02-27 | 9,000 | $57.38 | 152,908 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-02-27 | 9,000 | $0.00 | 9,000 | $57.38 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-02-27 | 64,132 | $0.00 | 64,132 | $57.38 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 9,316 | 2015-04-24 | 2025-04-24 | No | 4 | M | Direct |
| 15,684 | 2016-02-23 | 2025-04-24 | No | 4 | M | Direct |
Footnotes
- The shares reported were acquired by the Reporting Person from exercising a portion of a stock option award expiring in 2025, pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was completed pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on 11/17/2023.
- The price reported in Column 4 is a weighted average price.
Billionaire Hedge Funds
